Position: Chief Physician, Oncology Ward 3
Academic position:
• Former Director, Department of Interventional Radiology, Harbin First Hospital
• Member, Professional Committee on Interventional Minimally Invasive Therapy, China
• Member, Heilongjiang Provincial Society of Interventional Medicine
• Member, Heilongjiang Provincial Society of Radiology
• Standing Committee Member, First Committee of the Heilongjiang Provincial Medical Imaging Management Professional Committee
• Vice Chairperson, Interventional Radiology Professional Committee of Hainan Province
• Committee Secretary, Harbin Radiology Society
• Expert for Medical Equipment Procurement and Tendering, Heilongjiang Province
• External Expert, Heilongjiang Provincial Office for the Mediation and Handling of Medical Disputes and Incidents
• Specially appointed expert, Harbin Medical Committee for Work-Related Injury Assessment
Areas of Expertise
Professor and Chief Physician; formerly served as the Director of the Department of Interventional Radiology at Harbin First Hospital.He has undergone advanced training in Japan, at the Department of Interventional Radiology of the First Affiliated Hospital of China Medical University (under Professor Xu Ke, former Chairman of the Chinese Society of Radiology), and at the Department of Interventional Radiology of the PLA General Hospital (under Professor Zhang Jinshan, a renowned master of interventional radiology in China).He focuses on minimally invasive interventional treatments for various malignant tumors and possesses deep expertise in areas such as endovascular interventional therapy (e.g., transarterial chemoembolization) and thermal/cryo-ablation (e.g., microwave ablation, Argon-Helium cryoablation).He specializes in comprehensive interventional therapy for systemic solid malignant tumors, including liver, lung, breast, pancreatic, cervical, renal, bladder, esophageal, and gastrointestinal cancers.He also has extensive clinical experience in managing tumor-related emergencies, such as massive hemoptysis in lung cancer and intractable hematuria or vaginal bleeding caused by pelvic tumors, using interventional hemostasis techniques.
